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&e aim of this study was to assess the oxidative stress status in eyes affected by synchysis scintillans and to compare it to
vitreoretinal disorders without synchysis scintillans. Human aqueous and vitreous humors were obtained during vitrectomy from
thirty-seven otherwise healthy patients that were randomly chosen among patients that had to undergo a 25-gauge pars plana
vitrectomy from the central vitreous cavity, for either synchysis scintillans (n� 16) or vitreoretinal disorders without synchysis
scintillans (n� 21), such as idiopathic epimacular membrane (n� 12), macular hole (n� 5), or rhegmatogenous retinal de-
tachment (n� 4). &e redox parameters thiobarbituric acid reactive substances (TBARS), a measurement of lipid peroxidation,
nitrite concentration, an estimate of nitric oxide (NO) production, 4-hydroxynonenal (4-HNE)-protein conjugates, a structural
protein modification by lipid peroxidation product 4-HNE, and the antioxidative activities of Cu,Zn-superoxide dismutase
(SOD), and catalase were measured in aqueous and vitreous humors and compared between synchysis scintillans affected and not-
affected patients. TBARS and nitrite levels of the vitreous humor were significantly higher in patients with synchysis scintillans as
compared to patients affected by vitreoretinal disorders without synchysis scintillans. Synchysis scintillans patients had sig-
nificantly lower activities of SOD and catalase both in aqueous and vitreous humors than patients with vitreoretinal disorders
without synchysis. &e consequently higher lipoperoxide-dependent 4-HNE production in synchysis scintillans was detectable in
aqueous and vitreous humors as a significant increased accumulation of 4-HNE-protein conjugates vs nonsynchysis vitreoretinal
disorders. Additionally, hyaluronic acid (HA) was significantly decreased in the vitreous body of synchysis scintillans patients.&e
data consistently show that synchisis scintillans is accompanied by a redox imbalance with increased oxidative modifications of
4-HNE proteins and loss of HA, both of likely importance for remote damages of the retina. It remains to be proven whether a
therapeutic strategy which targets oxidative stress may be effective in the treatment of synchysis patients.
1. Introduction
Normal aging eye is accompanied by a number of physio-
logical changes in the vitreous gel, that is, a compact, ho-
mogeneous, and clear body at birth and that can undergo
progressive degeneration characterized by vitreous lique-
faction (synchysis) and weakening of the vitreoretinal ad-
hesion between the posterior vitreous hyaloid and the inner
limiting membrane. &is degeneration, corresponding with
a simultaneous decrease in gel volume, a lateral aggregation
of the collagen fibrils (syneresis), and a gradual destruction
of the collagen-hyaluronate network, may result in posterior
vitreous detachment (PVD) [1, 2].&us, PVD could increase
the risks of major vitreous retinal diseases such as macular
holes, epimacular membranes, vitreoretinal traction syn-
drome, and retinal detachment [3].
Next to vitreous retinal diseases, synchysis scintillans is a
rare bilateral condition characterized by the presence of tiny
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yellowish-white floating crystals of cholesterol in the vit-
reous. It tends to occur in eyes that have had uveitis or
vitreous haemorrhage, and it is a degenerative change.
Moreover, also the senile synchysis scintillans, resulting in
liquefied vitreous humor and the accumulation of choles-
terol crystals within the vitreous, seems to be involved in the
onset of PVD due to the possible vitreous instability, even if
only a dated study was reported and performed in eyes of
autopsied subjects [3].
An imbalance between free radicals production and
antioxidant defenses may produce oxidative stress (OS). &e
most important oxidants are reactive oxygen species (ROS)
and reactive nitrogen species (RNS) that have been impli-
cated as causative factors of many diseases and also involved
in aging because of their potential to cause oxidative de-
terioration of DNA, proteins, and lipids [4], resulting in
functional impairment, damage, and inflammation. In many
vitreoretinal disorders, such as proliferative diabetic reti-
nopathy (PDR), retinitis pigmentosa, age-related macular
degeneration, and rhegmatogenous retinal detachment
(RRD), OS has been implicated as a factor inducing the
development of retinal cellular damage [5].
&e aim of the present study was to assess oxidative stress
in aqueous and vitreous humors in patients undergoing the
25-gauge pars plana vitrectomy for typical vitreoretinal
diseases such as macular hole, idiopathic epimacular
membrane, or retinal detachment and in patients affected by
synchysis scintillans as vitreous disease. Indeed, as these
diseases may be sight-threatening conditions, there is
growing interest in unveiling their pathogenic mechanisms
to potentially lead to novel therapeutic strategies for their
prevention.
2. Methods
2.1. Patients. &e study was carried out in accordance with
the Declaration of Helsinki for medical research involving
human subjects in the period from February 2016 to June
2018 and was authorized by the local Ethical Committee (ref.
number: 0018536). Signed and written informed consent
was obtained from all patients accepting to be included in
this study. All patients went through a baseline ophthal-
mological examination before laser capsulotomy including
measurement of best-corrected visual acuity (BCVA),
Goldmann applanation tonometry, and fundus
examination.
&irty-seven otherwise healthy patients were randomly
chosen among patients that had to undergo a 25-gauge pars
plana vitrectomy from the central vitreous cavity, for idi-
opathic epimacular membrane (IEM) (n= 12), macular hole
(MH) (n= 5), rhegmatogenous retinal detachment (RRD)
(n= 4), and synchysis scintillans (SS) (n= 16). &e mean age
of the patients affected by vitreoretinal disorders and syn-
chysis scintillans was 74.0± 2.8 and 75.9± 2.1 years, re-
spectively. Patients did not receive pre- or postoperative
medications. &e following clinical characteristics were
recorded, and patients presenting with one or more of the
criteria were excluded from the study: vitreous hemorrhages
or hemovitreous, proliferative diabetic retinopathy, taking
antioxidant integrators, impossibility of classifying vitreous
degeneration or any of the other relevant parameters, in-
fections, malignant neoplasias, renal or hepatic failure, and
pathologic levels of blood glucose and fibrinogen.
2.2. Reagents. Unless otherwise specified, reagents were
purchased from Sigma-Aldrich (Milan, Italy), whereas
plasticware was from Falcon (Becton Dickinson, Franklin
Lakes, NJ).
2.3. Vitrectomy and Preparation of Aqueous and Vitreous
Samples. From each patient, an aqueous (130–150 μl) and a
vitreous (900–920 μl) sample were collected at the beginning
of the 25-gauge pars plana minimally invasive vitrectomy
with noncontact technique (BIOM) from the central vit-
reous cavity [6, 7]. Undiluted samples were immediately
placed in cryotubes and stored at − 80°C until assayed 2
weeks after sampling at the latest. After sample collection,
any type of contamination or exposure to light sources can
be excluded. &e aqueous and vitreous samples from each
patient were thawed and centrifuged to eliminate cellular
components and debris [8].
2.4. Measurement of +iobarbituric Acid Reactive Substance
(TBARS) Production. Following the indication by Yano, the
TBARS assay was used to detect the presence of lipid per-
oxidation products in vitreous samples, only, due to material
restrictions of the aqueous sample [9]. As previously re-
ported [8], 600 μl of the thawed clear vitreous supernatant
was sonicated with a 10 s burst using a Bandelin Sonopuls
HD 2070 sonicator with a titaniummicrotip MS73 at 30% of
maximal potency (corresponding to 60W), centrifuged at
16,124×g for 5min, and 500 μl of supernatant was added to
the TBA solution (thiobarbituric acid 0.375% and tri-
chloroacetic acid 30% in 0.5 N HCl). TBARS generation by
sonication was excluded. &e samples were boiled for
20min, then rapidly cooled in ice, and centrifuged for 5min
at 14,883×g. Absorbance on 300 μl of the sample was
measured at 532 nmwith a Packard EL340 microplate reader
(BioTek Instruments, Winooski, VT). Results are expressed
as nmol TBARS/ml sample. Reproducibility of TBARS
measurement in cell-free vitreous fluid samples had been
previously verified to justify the single-value analysis which
was necessary due to small available sample volumes. Ad-
ditionally, the determined HNE-protein conjugates com-
plement and support the TBARS data.
2.5. Measurement of Nitric Oxide (NO) Production. &e
concentration of nitrite, a stable product of nitric oxide
(NO), was measured in vitreous humor with the Griess
method, as described in [10]. &e resulting concentration
was expressed as nmol nitrite/ml sample.
2.6. Cu,Zn-Superoxide Dismutase (SOD) and Catalase
Activity. As the levels of reactive oxygen species in vitreous
and aqueous samples resulted to be poorly detectable in
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preliminary experiments, we measured the activities of SOD
and catalase activities as representative enzymes for local
antioxidative defense, as described in [8, 11], in 50 μl
aqueous and vitreous supernatants.
Briefly, SOD activity was measured by a specific SOD
assay (Trevigen, Tema Ricerca Srl, Bologna, Italy) using the
xanthine/xanthine oxidase/nitroblue tetrazolium (NBT)
system to generate and quantitate superoxide ion. SOD
prevents superoxide-mediated reduction of NBTand lowers
the yield of blue NBT-diformazan. 50 μl of sample was added
to 200 μl of reaction mix containing xanthine solution,
xanthine oxidase, and NBT and immediately assayed for
total SOD and specific Cu,Zn-SOD activity at 560 nm using a
Lambda 3 spectrophotometer (Bio-Rad Laboratories, Her-
cules, California). To evaluate the contribution of Cu,Zn-
SOD activity to the total activity, Mn-SOD and Fe-SODwere
inactivated by adding 100 μl of chloroform/ethanol (37.5/
62.5, v/v) to the supernatant before assay. Cu,Zn-SOD ac-
tivity was expressed as units per ml of supernatant.
Catalase activity was measured in 50 μl aqueous and
vitreous supernatants as reduction of H2O2 at 25°C by the
spectrophotometric method [11] at 240 nm on UV/Vis
spectrophotometer. &e catalase-specific activity was
expressed as units per ml of supernatant.
2.7. 4-Hydroxynonenal (HNE)-Protein Conjugate Assay.
&e accumulation of 4-HNE-protein conjugates represents
the local oxidative status and lipoperoxidation process. At
high concentration, 4-HNE is a bioactive toxic end-product
of lipoperoxides that is reported as important patho-
mechanistic factor in many disease [12, 13]. As to its ex-
ceptional reactivity, its conjugates with proteins can be
assessed by specific antibodies against the conjugate in
western blot. Proteins were extracted from 30 μl of vitreous
and 30 μl aqueous humor samples in presence of a protease
inhibitor cocktail (Complete®, Roche Diagnostics S.p.A.,Milano, Italy) in order to inhibit a broad spectrum of serine-,
cysteine-, and metalloprotease activities, centrifugated at
2000×g at 4°C for 10min to eliminate insoluble residues,
and quantified for protein content by Bio-Rad Protein Assay
(Bio-Rad, Hercules, CA, USA). As previously described [8],
protein was extracted with SDS-containing modified
Laemmli buffer (final concentrations of Tris-HCl 60mM,
EDTA 1mM, 5% glycerol, and SDS 2%), pH 6.8, at 95°C for
5min. Aliquots were kept at − 20C until use and β-mer-
captoethanol (5% v/v, final concentration) was added before
SDS-PAGE. &e extracted proteins were requantified,
loaded at 20 μg/lane, and separated in a 10% polyacrylamide/
acrylamide (w/v) SDS-PAGE. Separated proteins were
transferred onto a nitrocellulose membrane (Amersham
Biosciences, Fairfield, Connecticut), and equality of loaded
and transferred protein amounts and of protein pattern of all
sample lanes was verified by Ponceau S staining. Image
acquisition, protein band intensity quantification, and
comparison of lanes were performed using ImageJ software
(version 1.46,Wayne Rasband, National Institutes of Health,
Bethesda, MD, USA). Membranes were blocked with bovine
serum albumin (BSA; dissolved at 5% (w/v) in phosphate-
buffered saline containing 0.1% (v/v) Tween) for 1 h and
subjected to the mouse monoclonal anti-4-HNE-conjugate
antibody at 1 : 2000 dilution (clone HNEJ-2, Abcam,
Cambridge, UK) overnight at 4 C [11, 14, 15]. &en mem-
branes were washed with PBS-Tween 0.1% and incubated
with the secondary anti-mouse horseradish peroxidase-
conjugated antibody (Amersham, Bucks, United Kingdom)
at 1 : 20000 dilution for 1 h at room temperature. &e PBS-
Tween 0.1%-washed membranes were analyzed for anti-
body-positive bands which were visualized by enhanced
chemiluminescence (ECL) and acquired and quantified with
Chemidoc MP equipment (Bio-Rad Laboratories, Hercules,
California), using the PDQuest software (Bio-Rad, version
7.2) according to manufacturer’s instructions. 4-HNE-
modified human serum albumin (4-HNE-HSA) [14, 15] was
prepared as reference sample for normalization of sample
conjugate values. For this, 0.1 μg 4-HNE-HSA was run in
parallel with samples in each gel. For densitometry analysis,
the values obtained for all 4-HNE-positive bands of a sample
were referred to the reference 4-HNE-HSA band, summa-
rized in each lane, and expressed as 4-HNE arbitrary units
for each patient.
2.8. Hyaluronic Acid (HA) Assay. HA assay was performed
in 20 μl of vitreous samples using the human hyaluronic acid
AlphaLISA® immunoassay kit according to the manufac-turer’s instructions (PerkinElmer, Waltham, Massachusetts,
United States). &e assay shows no cross-reactivity with
human collagen Type I, Type II, Type III, and fibronectin.
Absorbance was measured at 615 nm with the EnSight in-
strument (PerkinElmer, Waltham, Massachusetts, United
States). Kaleido version 2.0.3058.126 and GraphPad Prism
(5.01) software were used for data acquisition and elabo-
ration. HA levels were expressed as ng HA/μl of vitreous
samples.
2.9. Statistical Analysis. Data were presented as mean ±
standard error of the mean (SEM), and the results were
checked for normal distribution and analyzed by one-way
analysis of variance (ANOVA) followed by Tukey’s test.
Statistical significance level was set at p � 0.05.
3. Results
In human, vitreous TBARS levels are significantly higher by
approximately 30% in patients affected by synchysis scin-
tillans compared to patients who underwent pars plana
vitrectomy for several vitreoretinal disorders without syn-
chysis such as idiopathic epimacular membrane (IEM),
macular hole (MH), or rhegmatogenous retinal detachment
(RRD) (Figure 1), indicating an increased lipid peroxidation.
We observed a significant decrease in antioxidant ac-
tivities of Cu,Zn-superoxide dismutase and catalase, in both
aqueous and vitreous humor, in the synchysis scintillans
group as compared to patients affected by any other vitre-
oretinal disorder under study (Figures 2 and 3). Comparing
the different types of vitreoretinal diseases, there were no
significant differences in the antioxidant enzyme activities
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(Figure 2 and 3) neither in the aqueous nor in the vitreous
compartment, although SOD and catase activities are sig-
nificantly highter in the vitreous compartment than in the
aqueous one, being far more expressed in the vitreous
compartment than in the aqueous one.
As no differences in TBARS, SOD, and catalase activity
levels were detectable between patient groups without
synchysis scintillans, IEM patients were chosen to serve as
representative controls for the synchysis scintillans group in
4-HNE-protein conjugate detection by western blotting. In
accordance with the TBARS data and antioxidative enzyme
activities, the level of proteins that were conjugated with the
lipoperoxidation product 4-HNE (Figure 4) was significantly
higher in aqueous versus vitreous humors of synchisis
scintillans patients, whereas both the aqueous and vitreous
supernatants derived from synchisis scintillans patients
contained a significantly higher level of 4-HNE-protein
conjugates than those from vitreoretinal patients.
Moreover, the vitreous nitrite levels in synchisis scintillans
patient group were about twice as high as in patients affected
by various vitreoretinal disease (Figure 5), whereas the vit-
reous HA amount was significantly less in synchisis scintillans
patients when compared to vitreoretinal disease patient
groups (Figure 6).
4. Discussion
Although the vitreous accounts for about 80% of the globe’s
eye volume and plays a crucial role in the pathogenesis of
various eye disorders, its physiologic role has been under-
estimated by ophthalmologists for long. &e mechanism of
vitreous liquefaction is not well understood, mainly due to
the few studies either in patients or postmortem studies.
Nevertheless, clinical evidence demonstrates that liquefac-
tion in conjunction with weakening of the vitreous cortex-
internal limiting laminar (ILM) adhesion, mostly when
liquefaction occurs faster than the detachment of the vit-
reous cortex or when an abnormal adhesion of the vitreous
cortex to the ILM occurs, results in PVD [16]. Previous
reports indicated that intravitreal oxidative stress provokes
disruption of hyaluronic acid leading to vitreous liquefaction
and ultimately PVD [17]. Consequently, PVD leads to the
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Figure 2: Low Cu,Zn-superoxide dismutase (SOD) activity in
aqueous and vitreous humors of patients with synchysis scintillans
as compared to other vitreoretinal diseases. Columns show
means± SEM of SOD activities measured in aqueous (AH) and
vitreous humors (VH) of patients with vitreoretinal diseases
without synchysis scintillans, i.e., idiopathic epimacular membrane
(IEM; n� 12), macular hole (MH; n� 5), rhegmatogenous retinal
detachment (RRD; n4), or patients with synchysis scintillans (SS;
n� 16). Measurements were performed in duplicate. Significant
differences are shown by ∗∗∗ at p< 0.001 between vitreous and
aqueous humors, by ○○○ at p< 0.001 between SS and any of
vitreoretinal patient groups in the aqueous humor, and by ••• at
p< 0.0001 between SS and any of vitreoretinal patient groups in the
vitreous humor.
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Figure 3: Low catalase activity in aqueous and vitreous humors of
patients with synchysis scintillans as compared to other vitreor-
etinal diseases. Columns show means± SEM of catalase activities
measured in aqueous (AH) and vitreous humors (VH) of patients
with vitreoretinal diseases without synchysis scintillans, i.e., idio-
pathic epimacular membrane (IEM; n� 12), macular hole (MH;
n� 5), rhegmatogenous retinal detachment (RRD; n4), or patients
with synchysis scintillans (SS; n� 16). Measurements were per-
formed in duplicate. Significant differences are shown by ∗∗∗ at
p< 0.001 between vitreous and aqueous humors, by ○○○ at
p< 0.0001 between SS and any of vitreoretinal patient groups in the
aqueous humor, and by ••• at p< 0.0001 between SS and any of
vitreoretinal patient groups in the vitreous humor.
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Figure 1: High thiobarbituric acid-reactive substances (TBARS)
levels in vitreous humor of patients with synchysis scintillans as
compared to other vitreoretinal diseases. Columns show means±
SEM of TBARS measured in vitreous humors of patients with
idiopathic epimacular membrane (IEM; n� 12), macular hole
(MH; n� 5), rhegmatogenous retinal detachment (RRD; n� 4), and
synchysis scintillans (SS; n� 16). Significant difference between SS
and other patient groups is indicated by ∗∗∗, at p≤ 0.001.
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abnormal vitreoretinal interface and vitreomacular traction
[18]. Particularly, on the basis of the direction of traction,
tractional force centripetal (inward toward the fovea) causes
macular pucker, whereas tangential traction in a centrifugal
direction (outward from the fovea) determines a macular
hole [16].
Also, IEM with largely collagen structures caused by glial
cells, hyalocytes, and myofibroblasts proliferation in the
macular area usually results in PVD process [19–21], through
a defect in the ILM and accompanied by a decrease in visual
acuity and disturbing metamorphopsia, photophobia, and
micropsia [22]. Furthermore, the rhegmatogenous retinal
detachment (RRD) is the most common type of detachment,
and it is characterized by a full-thickness break in the neural
retina leading to vitreous fluid influx into the subretinal space.
&us, RRD causes photoreceptor cells to lose direct contact
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Figure 4: High 4-HNE-protein conjugates in aqueous and vitreous humors of patients with synchysis scintillans as compared to other vit-
reoretinal diseases. (a) Representative pattern of 4-HNE-protein conjugates extracted from the vitreous and aqueous humors of patients affected by
idiopathic epimacular membrane or synchisis scintillans. Protein extracts were electrophoretically separated and western blotted, using antibody
against anti-4-HNE-conjugates: purified human serum albumin (HSA) and 4-HNE-conjugated HSA (4-HNE-mod HSA) were used as negative
and positive controls, respectively, to test the specificity of the method.&e protein bands of the analyzed humors were quantified (see Section 2),
and the values, expressed as arbitrary units, are represented in (b) as means± SEM. Significant differences are shown by ∗ at p< 0.01.
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Figure 5: High nitrite levels in vitreous humors of patients with
synchysis scintillans as compared to other vitreoretinal diseases.
Columns show means± SEM of nitrite concentrations in vitreous
humors of patients with idiopathic epimacular membrane (IEM;
n� 12), macular hole (MH; n� 5), rhegmatogenous retinal de-
tachment (RRD; n� 4), or synchysis scintillans (SS; n� 16). Nitrite
concentration was determined in duplicate per patient and only in
vitreous humor due to small available sample volumes. Significant
difference between SS and all other patient groups is indicated by∗∗∗ at p≤ 0.001.
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Figure 6: Low hyaluronic acid (HA) levels in vitreous humors of
patients with synchysis scintillans as compared to vitreoretinal
diseases without synchysis scintillans. Columns showmeans± SEM
of hyaluronic acid concentrations in vitreous humors of patients
with idiopathic epimacular membrane (IEM; n� 12), macular hole
(MH; n� 5), rhegmatogenous retinal detachment (RRD; n� 4), or
synchysis scintillans (SS; n� 16). HA concentration was de-
termined in duplicate per patient in vitreous humor. Significant
difference between SS and all other patient groups is indicated by∗∗∗ at p≤ 0.001.
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with the retinal pigment epithelium (RPE), exposes them to
liquid vitreous humor, and forms a diffusional barrier to the
flux of oxygen and nutrients coming from the RPE and the
choroid vasculature. &e resultant hypoxia and nutrient
deprivation are evidenced by the upregulation of hypoxia-
inducible factors (HIFs) in experimental models of RRD [23].
Moreover, recently, Kiang et al. have documented that ele-
vated levels of cytokines and growth factors in the vitreous of
retinal detachment patients contributed to the onset of
proliferative vitreoretinopathy in patients with retinal de-
tachment [24].
Next to these vitreoretinal diseases, the synchysis scin-
tillans is a degenerative condition of the eye resulting in
liquefied vitreous humor, and it is formed of multiple vit-
reous opacities that are flat, mobile, and golden brown in
color with the collagen displaced peripherally [16, 25, 26].
Synchysis scintillans is not well studied from a biomolecular
point of view as it is a rare condition, also known as
“cholesterolosis bulbi,” as the presence of refringent cho-
lesterol crystals was demonstrated in these opacities [16].
&e developed cholesterol crystals, clinically detectable
anterior chamber, is to be attributed to different pathoge-
netic mechanisms following the breakdown of vitreous and
anterior chamber haemorrhage or deriving from the sub-
retinal fluid of a chronic total retinal detachment in the
absence of any intraocular haemorrhage resulting from
phacolysis and associated with a marked neutrophil re-
sponse [27].
In this paper, we propose OS and lipoperoxidation as
causative factors in cholesterol crystal formation. It is well
known that oxidative stress is a common denominator
link for the major pathways which are involved in the
disease development and progression for clinical com-
plications. Indeed, there is increasing evidence indicating
that persistent OS contributes to the development of many
ocular diseases, among which are noncancer ocular dis-
eases (dry eye syndrome, corneal and conjunctive dis-
eases, cataract, glaucoma, retinitis pigmentosa, diabetic
retinopathy, and autoimmune and inflammatory uveitis)
and cancer ocular diseases (melanoma, retinoblastoma,
and lymphoma) [4]. Moreover, the increase in vitreous
cytokine mRNA expression and concentrations in human
RRD shows that oxidative stress status is a significant
component of the retina’s response in photoreceptor
degeneration [28]. &e eye is one of the major targets of
the ROS/RNS attack due to exposition on several envi-
ronmental factors like light exposure, ultraviolet rays,
ionizing radiation, chemical pollutants, irritant, high
pressure of oxygen, pathogenic microbes, and also
Q-switched Nd:YAG treatment [8], which are able to shift
the redox status of a cell toward oxidizing conditions [29].
&e role of OS in synchysis scintillant condition in not
studied well even if the failure in the efficiency of anti-
oxidant system as one of the causes of vitreous opacities
was supposed as early as in 1929 [30]. Notably, ROS and
lipoperoxidation products including HNE were shown to
be causative for cholesterol monohydrate crystal forma-
tion in supersaturated model bile [31]. Moreover, the lipid
peroxidation is known to promote formation of crystalline
structures of free cholesterol [32], suggesting the high level of
HNE in synchysis patients could be mechanistic for choles-
terol crystal formation. Additional indirect evidence of the
role of lipoperoxidation in synchysis scintillans pathogenesis
is that rabbits fed a diet rich in cholesterol developed syn-
chysis scintillans with abnormally high deposition of extra-
vascular lipid material [33] which is a good substract for
lipoperoxidation.
In the present study, we highlighted that, in all the in-
vestigated eye pathologies, there is an oxidative status con-
dition measured as presence of TBARS levels and 4-HNE
products, in both aqueous and vitreous humors, that is, sig-
nificantly more evident in patients affected by vitreous disease
compared to those having vitreoretinal diseases. Moreover, in
synchisis scintillans patients, the vitreous nitrite levels were
significantly higher compared to the nitrite levels in patients
affected by various vitreoretinal diseases. Extensive research
during the past three decades has demonstrated the mecha-
nisms by which an imbalance in the redox status of proox-
idant/antioxidant reactions in cells with advantage of
prooxidant reactions can cause peroxidation of nucleic acids,
bases, lipids, proteins, and carbohydrates, thus resulting in
their damage leading to chronic inflammation and causing
tissue dysfunction [29]. Our data show that the antioxidative
activities of SOD and catalase are significantly lower in syn-
chisis scintillans group compared with patients affected by
vitreoretinal disorders, confirming that dysregulation of SOD
and catalase activities at the vitreous base may be critical in the
pathophysiology of oxidative stress-related vitreoretinopathies.
Moreover, our results demonstrated that, in synchisis scin-
tillans patients, the amount of HA was significantly less
compared to patients affected by vitreoretinal disease. Free
radicals generated by metabolic reactions as well as the
presence of cholesterol crystals could alter hyaluronan and/or
collagen structure and trigger a dissociation of collagen and
hyaluronanmolecules [34], which ultimately results in vitreous
liquefaction [35, 36].
In our opinion, it is plausible that the development of
synchisis scintillans could be attributed to frequent or chronic
proinflammatory states, as allergic infections never diagnosed
within mild symptoms, that could explain an accumulation of
activated macrophages-derived cholesterol-forming crystals in
the eye [37]. As a consequence, even if synchisis scintillans is
sometimes considered a clinically insignificant condition, the
retina is certainly exposed to irregular light exposure that
could result in retinal damage and degenerations [38].
Moreover, also the cholesterol crystals could trigger inflam-
masome-mediated innate responses activation leading to
retinal damage [36, 39] and adding additional clinical sig-
nificance to synchisis scintillans.
A better understanding of response to oxidative stress
related to eye pathologies will lead to new therapeutic ap-
proaches for the prevention or amelioration of age-associ-
ated degenerative diseases.
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